The Hair Loss Encyclopedia

Topical Minoxidil Therapy for Androgenic Alopecia in the Middle East

October 1993 in “ International Journal of Dermatology ”

Paula Stephania Brandão Hage Karam

topical minoxidil androgenic alopecia hair regrowth nonvellus hairs Rogaine

Studysummary This study found that 2% minoxidil led to moderate to dense hair growth in 80% of Middle-Eastern men treated for 48 weeks with early androgenic alopecia.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

In 1993, a 48-week open label trial was conducted in five Middle-Eastern countries with 195 men aged 19 to 47 years to evaluate the effectiveness and safety of 2% topical minoxidil for treating early androgenic alopecia. The trial concluded with no significant changes in vital signs or laboratory parameters, indicating safety. Out of 161 evaluable patients at the end of the study, 80% experienced moderate to dense hair regrowth, with an average increase of 234 nonvellus hairs. The study determined that the age of the patient and the type of baldness were more influential on the outcome than the duration of baldness. The efficacy of 2% minoxidil in this Middle Eastern cohort was higher than that observed in previous studies from the USA and Europe, where only 39% of patients showed moderate to dense hair growth. The findings suggested that patient age and baldness type should be key criteria for selecting candidates for minoxidil treatment in the Middle East.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Treatment of Male Pattern Alopecia Using Topical Minoxidil in The Netherlands

23 citations , July 1988 in “International Journal of Dermatology”

This study found that 2% minoxidil solution was about three times more effective than a placebo in improving hair growth in men with early male pattern alopecia over 24 weeks.

research The Belgian Ten-Center Open Label Trial of Topical 2% Minoxidil Solution in Early Male Pattern Alopecia

3 citations , July 1988 in “International Journal of Dermatology”

This study observed that topically applied 2% minoxidil solution significantly increased hair counts in men with early male pattern alopecia over 24 weeks, with no serious safety concerns.

Androgenetic Alopecia Treated With Topical Minoxidil

research Androgenetic Alopecia Treated With Topical Minoxidil

32 citations , March 1987 in “Journal of The American Academy of Dermatology”

Using minoxidil on balding men's scalps can increase hair growth, according to a 12-month study.

Safety and Efficacy of Topical Minoxidil in the Management of Androgenetic Alopecia

research Safety and Efficacy of Topical Minoxidil in the Management of Androgenetic Alopecia

67 citations , March 1987 in “Journal of The American Academy of Dermatology”

This study found that both 2% and 3% minoxidil resulted in a significant increase in hair counts for participants with androgenetic alopecia over 12 months.

Long-Term Efficacy of Topical Minoxidil in Male Pattern Baldness

research Long-Term Efficacy of Topical Minoxidil in Male Pattern Baldness

41 citations , March 1987 in “Journal of The American Academy of Dermatology”

This study observed that 2% minoxidil solution was at least as effective as 3% for increasing hair growth and stabilizing bald areas in men with male pattern baldness.

Topical Minoxidil Therapy in Hereditary Androgenetic Alopecia

research Topical Minoxidil Therapy in Hereditary Androgenetic Alopecia

55 citations , February 1985 in “Archives of Dermatology”

In this randomized trial, topical minoxidil treatment resulted in cosmetically acceptable hair growth in 32% of men with hereditary male pattern baldness, with no serious side effects reported.